Gary Charles Robb, Chief Financial Officer at CORCEPT THERAPEUTICS INC (CORT), sold 50,000 shares at $19.01 ($951K) on 2018-12-12, disclosed to the SEC on 2018-12-14.
Open-market sale of $950k CORT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.01 | 25,000 | $475K | 50.0% |
| 2 | $19.01 | 25,000 | $475K | 50.0% |
| Total | $19.01 avg | 50,000 | $951K | 100% |
| Filing → |
| CORT | SELL | 2025-06-18 | $451K | — | Filing → |
| CORT | SELL | 2025-05-22 | $346K | — | Filing → |
| CORT | SELL | 2025-01-06 | $556K | — | Filing → |